Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings

View ORCID ProfileJustin K. Sheen, View ORCID ProfileJohannes Haushofer, View ORCID ProfileC. Jessica E. Metcalf, View ORCID ProfileLee Kennedy-Shaffer
doi: https://doi.org/10.1101/2021.07.12.21260375
Justin K. Sheen
1Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Justin K. Sheen
Johannes Haushofer
2Department of Economics, Stockholm University, Stockholm, Sweden
3Research Institute of Industrial Economics, Stockholm, Sweden
4Max Planck Institute for Collective Goods, Bonn, Germany
5Jain Family Institute, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Johannes Haushofer
C. Jessica E. Metcalf
1Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
6School of Public and International Affairs, Princeton University, Princeton, NJ, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C. Jessica E. Metcalf
Lee Kennedy-Shaffer
7Department of Mathematics and Statistics, Vassar College, Poughkeepsie, NY, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lee Kennedy-Shaffer
  • For correspondence: lkennedyshaffer{at}vassar.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.07.12.21260375
History 
  • July 16, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.

Author Information

  1. Justin K. Sheen1,
  2. Johannes Haushofer2,3,4,5,
  3. C. Jessica E. Metcalf1,6 and
  4. Lee Kennedy-Shaffer7,*
  1. 1Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
  2. 2Department of Economics, Stockholm University, Stockholm, Sweden
  3. 3Research Institute of Industrial Economics, Stockholm, Sweden
  4. 4Max Planck Institute for Collective Goods, Bonn, Germany
  5. 5Jain Family Institute, New York, USA
  6. 6School of Public and International Affairs, Princeton University, Princeton, NJ, USA
  7. 7Department of Mathematics and Statistics, Vassar College, Poughkeepsie, NY, USA
  1. ↵*Correspondence: Lee Kennedy-Shaffer, lkennedyshaffer{at}vassar.edu
Back to top
PreviousNext
Posted July 16, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings
Justin K. Sheen, Johannes Haushofer, C. Jessica E. Metcalf, Lee Kennedy-Shaffer
medRxiv 2021.07.12.21260375; doi: https://doi.org/10.1101/2021.07.12.21260375
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The required size of cluster randomized trials of non-pharmaceutical interventions in epidemic settings
Justin K. Sheen, Johannes Haushofer, C. Jessica E. Metcalf, Lee Kennedy-Shaffer
medRxiv 2021.07.12.21260375; doi: https://doi.org/10.1101/2021.07.12.21260375

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)